TP53 and cancer: It has been reported that U0126, an inhibitor of mitogen-activated protein kinase kinase (MEK)/ERK signaling significantly inhibits oleanolic acid-induced p53 expression in HepG2 cancer cells [17], suggesting that p53 is regulated by ERK1/2 signaling pathway.